We confirmed the down-regulation of E2F1 and E2F2 expression in three different cancer cell lines, SW780, A549 and SBC5 treated with siRNAs, by quantitative real-time PCR (Figure 6A and 6B). The gene discussed is E2F2; the disease is cancer.